Christopher Astle, SVP & Chief Financial Officer at Zymeworks Inc. (ZYME), sold 5,994 shares at $11.22 ($65K) on 2024-01-08, disclosed to the SEC on 2024-01-08.
Open-market sale of $65k ZYME by SVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.65 | 4,563 | $49K | 75.2% |
| 2 | $11.22 | 1,431 | $16K | 24.8% |
| Total | $10.79 avg | 5,994 | $65K | 100% |
| Filing → |